Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 205,568,293 papers from all fields of science
Search
Sign In
Create Free Account
CP 532,623
Known as:
CP532623
, CP-532623
, CP 532623
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Quinolines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Correlating in Vitro Solubilization and Supersaturation Profiles with in Vivo Exposure for Lipid Based Formulations of the CETP Inhibitor CP-532,623.
Claire L. McEvoy
,
N. Trevaskis
,
+4 authors
C. Porter
Molecular pharmaceutics
2017
Corpus ID: 40370219
Lipid based formulations (LBFs) are a promising formulation strategy for many poorly water-soluble drugs and have been shown…
Expand
2014
2014
In vitro-in vivo evaluation of lipid based formulations of the CETP inhibitors CP-529,414 (torcetrapib) and CP-532,623.
Claire L. McEvoy
,
N. Trevaskis
,
+5 authors
C. Porter
European journal of pharmaceutics and…
2014
Corpus ID: 7596915
2010
2010
The Role of the Intestinal Lymphatics in the Absorption of Two Highly Lipophilic Cholesterol Ester Transfer Protein Inhibitors (CP524,515 and CP532,623)
N. Trevaskis
,
Claire L. McEvoy
,
+4 authors
C. Porter
Pharmaceutical Research
2010
Corpus ID: 24785379
ABSTRACTPurposeTo evaluate the potential role of intestinal lymphatic transport in the absorption and oral bioavailability of…
Expand
2009
2009
Effects of CP-532,623 and Torcetrapib, Cholesteryl Ester Transfer Protein Inhibitors, on Arterial Blood Pressure
E. Blasi
,
M. Bamberger
,
+6 authors
J. Keiser
Journal of cardiovascular pharmacology
2009
Corpus ID: 23463857
ILLUMINATE, the phase 3 morbidity and mortality trial of the cholesteryl ester transfer protein (CETP) inhibitor, torcetrapib…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE